The EU authorisation triggers a $75 million milestone payment from AstraZeneca to Daiichi Sankyo for the adjuvant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results